Secondary Safety Analysis of Different COVID-19 Vaccines and mRNA Products in a Cohort of 46 Million Participants in England

We performed a secondary safety analysis of different COVID-19 vaccines from several large UK data sets. The original published studies did not perform such analyses. We assessed confidence intervals of the ratio of hazard ratios for the following published studies: Ip et al (45.7M participants) [1…